Welcome to LookChem.com Sign In|Join Free
  • or
diethyl 4-[N-(2-cyanophenyl)carbamoyl]benzyl-phosphonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

166395-00-2

Post Buying Request

166395-00-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

166395-00-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 166395-00-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,3,9 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 166395-00:
(8*1)+(7*6)+(6*6)+(5*3)+(4*9)+(3*5)+(2*0)+(1*0)=152
152 % 10 = 2
So 166395-00-2 is a valid CAS Registry Number.

166395-00-2Relevant academic research and scientific papers

Phosphonic diester derivatives

-

, (2008/06/13)

The present invention provides a phosphonic diester derivative of the following general formula (1): STR1 wherein A represents an oxygen atom or a sulfur atom; R1, R2, R9 and R10 are the same or different and th

Synthesis and hypolipidemic activities of novel 2-[4-[(diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones

Kurogi, Yasuhisa,Inoue, Yasuhide,Tsutsumi, Kazuhiko,Nakamura, Shizuo,Nagao, Kazushi,Yoshitsugu, Hiroki,Tsuda, Yoshihiko

, p. 1433 - 1437 (2007/10/03)

The novel compound NO-1886, 4-[(diethoxyphosphoryl)methyl]-N-(4-bromo-2-cyanophenyl)-benzamide, is a hypolipidemic agent, which appears to increase lipoprotein lipase activity in rats. Various analogs of NO-1886 were synthesized to study the structure-act

Method for treating hyperlipidemia

-

, (2008/06/13)

A pharmaceutical composition for treating hyperlipidemia containing, as the active ingredient, at least one carboxamide compounds represented by the formula (1) which possess excellent activities in lowering serum lipid, as well as having low toxicity with high safety. Said carboxamide compounds represented by the formula (1) are known compounds developed by the present inventors, but the pharmacological activities for treating hyperlipidemia have not been found yet.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 166395-00-2